- 期刊
One-Year Follow-Up after Percutaneous Coronary Intervention with Titanium-Nitride-Oxide-Coated Stents Versus Paclitaxel-Eluting Stents in Patients from Real-World Clinical Practice
並列摘要
Background: Drug-eluting stents significantly decreased intimal hyperplasia in comparison with bare metal stents; however, safety issues have been reported by recent studies. In this study, titanium-nitride-oxide-coated stents, which exhibit less thrombogenicity, were compared to paclitaxel-eluting stents with respect to the rate of major adverse cardiovascular events (MACE).Methods: One hundred and fourteen patients [65 in titanium-nitride-oxide-coated (Titan(superscript ®)) stent group and 49 in paclitaxel-eluting (TAXUS(superscript ®)) stent group] were enrolled in a single teaching hospital in northern Taiwan between November 2005 and October 2008. Patients with acute coronary syndrome or chronic stable angina with a positive myocardial thallium scan were eligible for the study, and patients who underwent percutaneous coronary intervention (PCI) with either Titan stents or TAXUS stents were enrolled. We evaluated the MACE rate in the two groups during the first year after stent placement.Results: The MACE rates of the Titan and TAXUS groups were 10.8% (7/65) and 6.1% (3/49), respectively, but the difference was not statistically significant (p=0.3). In addition, the 12-month clinical outcomes were not statistically different between the groups. In a comparison of the risk factors of diabetes mellitus, acute myocardial infarction, hypertension, smoking, and dyslipidemia between the two groups, there was no significant difference in the rates of MACE.Conclusion: There was no difference in MACE or all-cause mortality at 12 months after stent implantation in patients who received the TAXUS or Titan stents.
延伸閱讀
- Alazzoni, A., Saleh, A. A., & Jolly, S. S. (2012). Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials. Thrombosis, 2012(), 26-33. https://doi.org/10.1155/2012/126369
- 林宜玲（2006）。Resources Utilization and Clinical Outcomes of Drug-Eluting Stent versus Bare Metal Stent in Coronary Artery Disease Patients〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0407200616133200
- Lai, C. C., & Mar, G. Y. (2016). Author Reply to Letter to the Editor: Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry. Acta Cardiologica Sinica, 32(1), 121-122. https://doi.org/10.6515/ACS20150504B
- Lai, C. C., Yip, H. K., Lin, T. H., Wu, C. J., Lai, W. T., Liu, C. P., Chanl, S. C., & Mar, G. Y. (2014). Drug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter Registry. Acta Cardiologica Sinica, 30(6), 553-564. https://doi.org/10.6515/ACS20140421B
- Jen, H. L., Yin, W. H., Chiang, M. C., Wang, J. J., Huang, W. P., Feng, A. N., Yang, Y. N., Lin, C. C., Tung, T. H., & Young, M. S. (2007). The Effects of Starting Statin Therapy Prior to Percutaneous Coronary Intervention with Drug-Eluting Stent on Postprocedural Myonecrosis and Clinical Outcome. Acta Cardiologica Sinica, 23(2), 71-78. https://www.airitilibrary.com/Article/Detail?DocID=10116842-200706-23-2-71-78-a